| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| NF-kappa B | 59 | 2024 | 466 | 8.700 |
Why?
|
| Apoptosis | 29 | 2023 | 1717 | 2.670 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 15 | 2009 | 114 | 2.270 |
Why?
|
| Antigens, Differentiation | 14 | 2018 | 141 | 2.170 |
Why?
|
| Neoplasm Proteins | 5 | 2021 | 540 | 1.660 |
Why?
|
| Signal Transduction | 30 | 2021 | 3387 | 1.580 |
Why?
|
| Neoplasms | 15 | 2024 | 3043 | 1.540 |
Why?
|
| MAP Kinase Kinase 7 | 9 | 2018 | 21 | 1.250 |
Why?
|
| Reactive Oxygen Species | 9 | 2010 | 490 | 1.240 |
Why?
|
| Multiple Myeloma | 5 | 2021 | 330 | 1.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 22 | 2010 | 699 | 1.030 |
Why?
|
| Transcription Factor RelA | 9 | 2021 | 49 | 0.970 |
Why?
|
| Colorectal Neoplasms | 2 | 2021 | 983 | 0.860 |
Why?
|
| Energy Metabolism | 3 | 2021 | 277 | 0.860 |
Why?
|
| Antineoplastic Agents | 6 | 2021 | 2415 | 0.770 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2021 | 24 | 0.770 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 1266 | 0.730 |
Why?
|
| Triglycerides | 1 | 2021 | 232 | 0.730 |
Why?
|
| Inflammation | 7 | 2022 | 971 | 0.720 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 217 | 0.700 |
Why?
|
| Cell Survival | 10 | 2017 | 983 | 0.690 |
Why?
|
| Caspases | 5 | 2023 | 155 | 0.690 |
Why?
|
| Nuclear Proteins | 4 | 2014 | 726 | 0.670 |
Why?
|
| Mitochondria | 5 | 2021 | 553 | 0.640 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2004 | 227 | 0.620 |
Why?
|
| Drugs, Investigational | 1 | 2017 | 39 | 0.590 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 179 | 0.570 |
Why?
|
| Animals | 53 | 2019 | 27387 | 0.570 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 3 | 2004 | 102 | 0.510 |
Why?
|
| Cytokines | 5 | 2018 | 803 | 0.510 |
Why?
|
| MAP Kinase Signaling System | 4 | 2006 | 198 | 0.500 |
Why?
|
| Models, Biological | 4 | 2017 | 1766 | 0.490 |
Why?
|
| Humans | 67 | 2024 | 89391 | 0.480 |
Why?
|
| Gene Expression Regulation | 15 | 2007 | 1976 | 0.480 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 4 | 2009 | 43 | 0.470 |
Why?
|
| Mice, Knockout | 17 | 2017 | 2002 | 0.410 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 401 | 0.400 |
Why?
|
| Cell Respiration | 1 | 2011 | 19 | 0.390 |
Why?
|
| Liver Regeneration | 2 | 2008 | 36 | 0.390 |
Why?
|
| Proto-Oncogene Proteins | 10 | 1999 | 666 | 0.370 |
Why?
|
| Fibroblasts | 3 | 2011 | 755 | 0.370 |
Why?
|
| Spleen | 7 | 2008 | 433 | 0.370 |
Why?
|
| Mice | 31 | 2017 | 11766 | 0.360 |
Why?
|
| Macrophages | 5 | 2024 | 572 | 0.350 |
Why?
|
| NF-kappa B p50 Subunit | 5 | 2024 | 42 | 0.340 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2007 | 198 | 0.340 |
Why?
|
| T-Lymphocytes | 11 | 2017 | 1224 | 0.330 |
Why?
|
| Education | 1 | 2009 | 58 | 0.320 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2015 | 447 | 0.320 |
Why?
|
| Enzyme Activation | 8 | 2015 | 698 | 0.320 |
Why?
|
| Ferritins | 2 | 2006 | 29 | 0.310 |
Why?
|
| Peptides | 3 | 2021 | 648 | 0.310 |
Why?
|
| Receptors, Tumor Necrosis Factor | 6 | 2006 | 90 | 0.310 |
Why?
|
| Up-Regulation | 7 | 2011 | 727 | 0.300 |
Why?
|
| Liver Diseases | 1 | 2009 | 242 | 0.290 |
Why?
|
| Hepatocytes | 1 | 2008 | 119 | 0.290 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 463 | 0.290 |
Why?
|
| MAP Kinase Kinase 4 | 5 | 2009 | 67 | 0.290 |
Why?
|
| Germinal Center | 2 | 1998 | 55 | 0.290 |
Why?
|
| Twist-Related Protein 1 | 1 | 2007 | 17 | 0.290 |
Why?
|
| fas Receptor | 3 | 2004 | 77 | 0.290 |
Why?
|
| Cell Proliferation | 3 | 2017 | 1653 | 0.280 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 573 | 0.280 |
Why?
|
| Gene Library | 1 | 2007 | 133 | 0.280 |
Why?
|
| Cell Line, Tumor | 6 | 2021 | 2558 | 0.270 |
Why?
|
| Cell Line | 16 | 2007 | 2496 | 0.270 |
Why?
|
| Health | 1 | 2006 | 29 | 0.270 |
Why?
|
| DNA-Binding Proteins | 10 | 1999 | 1242 | 0.270 |
Why?
|
| Homeostasis | 2 | 2022 | 417 | 0.260 |
Why?
|
| Disease | 1 | 2006 | 90 | 0.250 |
Why?
|
| Transcriptional Activation | 6 | 2002 | 294 | 0.250 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2005 | 51 | 0.240 |
Why?
|
| Mycoplasma pneumoniae | 2 | 1994 | 6 | 0.230 |
Why?
|
| Pneumonia, Mycoplasma | 2 | 1994 | 8 | 0.230 |
Why?
|
| CD40 Antigens | 1 | 2003 | 44 | 0.220 |
Why?
|
| Molecular Targeted Therapy | 2 | 2017 | 286 | 0.210 |
Why?
|
| I-kappa B Proteins | 7 | 2003 | 54 | 0.210 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 44 | 0.210 |
Why?
|
| Promoter Regions, Genetic | 5 | 2015 | 956 | 0.210 |
Why?
|
| Immune Tolerance | 2 | 2017 | 339 | 0.200 |
Why?
|
| Molecular Sequence Data | 11 | 2008 | 3027 | 0.200 |
Why?
|
| Protein Interaction Mapping | 2 | 2021 | 82 | 0.200 |
Why?
|
| Osteoclasts | 2 | 1999 | 35 | 0.190 |
Why?
|
| Cell Fractionation | 1 | 2021 | 71 | 0.190 |
Why?
|
| Autoimmunity | 1 | 2022 | 168 | 0.190 |
Why?
|
| Peptide Library | 1 | 2021 | 84 | 0.180 |
Why?
|
| B-Lymphocytes | 3 | 2003 | 739 | 0.180 |
Why?
|
| Necrosis | 3 | 2011 | 209 | 0.180 |
Why?
|
| Transfection | 10 | 2011 | 911 | 0.180 |
Why?
|
| Lumbar Vertebrae | 2 | 2013 | 151 | 0.170 |
Why?
|
| Oxygen | 1 | 2005 | 743 | 0.170 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2017 | 394 | 0.170 |
Why?
|
| Stress, Physiological | 2 | 2021 | 232 | 0.170 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2021 | 154 | 0.160 |
Why?
|
| Cells, Cultured | 7 | 2014 | 2884 | 0.160 |
Why?
|
| Respiration | 1 | 2021 | 266 | 0.160 |
Why?
|
| Phosphorylation | 6 | 2021 | 1132 | 0.160 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 48 | 0.160 |
Why?
|
| RNA Interference | 4 | 2015 | 376 | 0.160 |
Why?
|
| Dendritic Cells | 3 | 2020 | 449 | 0.150 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1998 | 47 | 0.150 |
Why?
|
| Transcription Factors | 12 | 2004 | 1654 | 0.150 |
Why?
|
| Multiprotein Complexes | 1 | 2018 | 96 | 0.150 |
Why?
|
| Drug Design | 1 | 2017 | 127 | 0.150 |
Why?
|
| Phenotype | 1 | 2024 | 2443 | 0.140 |
Why?
|
| Crohn Disease | 1 | 2023 | 762 | 0.140 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2011 | 414 | 0.140 |
Why?
|
| Amino Acid Sequence | 7 | 2008 | 2062 | 0.140 |
Why?
|
| Monocytes | 2 | 1994 | 218 | 0.130 |
Why?
|
| Mycoplasma fermentans | 2 | 1993 | 2 | 0.130 |
Why?
|
| Transcription, Genetic | 6 | 2015 | 1157 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 6 | 2017 | 3220 | 0.130 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2012 | 51 | 0.130 |
Why?
|
| Pan troglodytes | 2 | 1994 | 200 | 0.120 |
Why?
|
| Telomerase | 1 | 2015 | 62 | 0.120 |
Why?
|
| T-Lymphocyte Subsets | 2 | 1998 | 275 | 0.120 |
Why?
|
| Serine Endopeptidases | 2 | 1994 | 146 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2009 | 323 | 0.120 |
Why?
|
| Biological Availability | 1 | 2014 | 92 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 8 | 2017 | 1057 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 126 | 0.120 |
Why?
|
| CD11b Antigen | 1 | 2014 | 36 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 605 | 0.110 |
Why?
|
| HIV-1 | 1 | 1994 | 166 | 0.110 |
Why?
|
| Osteophyte | 1 | 2013 | 2 | 0.110 |
Why?
|
| Hardness Tests | 1 | 2013 | 3 | 0.110 |
Why?
|
| Ubiquitination | 2 | 2015 | 73 | 0.110 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2014 | 91 | 0.110 |
Why?
|
| Weight-Bearing | 1 | 2013 | 67 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2007 | 618 | 0.110 |
Why?
|
| Virus Replication | 1 | 1994 | 324 | 0.110 |
Why?
|
| Mice, Inbred Strains | 3 | 1998 | 308 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2015 | 382 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2012 | 6 | 0.110 |
Why?
|
| Cell Death | 4 | 2010 | 262 | 0.110 |
Why?
|
| Antigens, Bacterial | 1 | 1993 | 136 | 0.100 |
Why?
|
| HeLa Cells | 2 | 2004 | 511 | 0.100 |
Why?
|
| Base Sequence | 8 | 2002 | 2327 | 0.100 |
Why?
|
| Lymphocyte Activation | 4 | 2010 | 751 | 0.100 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2011 | 12 | 0.100 |
Why?
|
| Joints | 1 | 2011 | 32 | 0.100 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 46 | 0.100 |
Why?
|
| Electron Transport Complex IV | 1 | 2011 | 49 | 0.100 |
Why?
|
| Binding Sites | 7 | 2002 | 1117 | 0.100 |
Why?
|
| Arthritis, Experimental | 1 | 2011 | 26 | 0.100 |
Why?
|
| Oxidative Phosphorylation | 1 | 2011 | 54 | 0.100 |
Why?
|
| Metabolic Syndrome | 1 | 2012 | 123 | 0.100 |
Why?
|
| Lactic Acid | 1 | 2011 | 92 | 0.100 |
Why?
|
| Mycoplasma | 1 | 1991 | 4 | 0.090 |
Why?
|
| Chlamydia trachomatis | 1 | 1991 | 15 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2004 | 387 | 0.090 |
Why?
|
| Lymphotoxin-alpha | 2 | 2008 | 44 | 0.090 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2010 | 46 | 0.090 |
Why?
|
| Molecular Chaperones | 1 | 2011 | 122 | 0.090 |
Why?
|
| Glycolysis | 1 | 2011 | 135 | 0.090 |
Why?
|
| Time Factors | 5 | 2015 | 5340 | 0.090 |
Why?
|
| Asbestos | 2 | 2010 | 22 | 0.090 |
Why?
|
| Oxygen Consumption | 1 | 2011 | 244 | 0.090 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2008 | 122 | 0.090 |
Why?
|
| HMGB1 Protein | 1 | 2010 | 16 | 0.090 |
Why?
|
| Adenosine Triphosphate | 1 | 2011 | 316 | 0.090 |
Why?
|
| Tumor Burden | 1 | 2011 | 308 | 0.090 |
Why?
|
| Interleukin-6 | 2 | 2008 | 261 | 0.090 |
Why?
|
| Synovitis | 1 | 2009 | 14 | 0.090 |
Why?
|
| Hepatitis | 1 | 2009 | 34 | 0.090 |
Why?
|
| Cell Physiological Phenomena | 1 | 2009 | 24 | 0.090 |
Why?
|
| Protein Binding | 5 | 2012 | 1488 | 0.080 |
Why?
|
| Mice, Nude | 1 | 2011 | 815 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 887 | 0.080 |
Why?
|
| Evolution, Molecular | 2 | 2006 | 842 | 0.080 |
Why?
|
| Repressor Proteins | 2 | 2007 | 423 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 73 | 0.080 |
Why?
|
| Lymphotoxin-beta | 1 | 2008 | 7 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2011 | 314 | 0.080 |
Why?
|
| Immune System Diseases | 1 | 2009 | 27 | 0.080 |
Why?
|
| Fractures, Spontaneous | 1 | 2008 | 11 | 0.080 |
Why?
|
| Membrane Microdomains | 1 | 2009 | 54 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 138 | 0.080 |
Why?
|
| Luciferases | 1 | 2009 | 128 | 0.080 |
Why?
|
| Autophagy | 2 | 2021 | 159 | 0.080 |
Why?
|
| Glucose | 1 | 2011 | 630 | 0.080 |
Why?
|
| Female | 6 | 2021 | 46238 | 0.080 |
Why?
|
| In Vitro Techniques | 3 | 2013 | 996 | 0.080 |
Why?
|
| Cell Nucleus | 5 | 2010 | 600 | 0.080 |
Why?
|
| Retinal Ganglion Cells | 1 | 2008 | 71 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2009 | 170 | 0.080 |
Why?
|
| Male | 6 | 2021 | 42434 | 0.080 |
Why?
|
| Structure-Activity Relationship | 2 | 2007 | 413 | 0.080 |
Why?
|
| Spinal Fractures | 1 | 2008 | 77 | 0.070 |
Why?
|
| NF-kappa B p52 Subunit | 2 | 2005 | 5 | 0.070 |
Why?
|
| B-Lymphocyte Subsets | 2 | 1998 | 40 | 0.070 |
Why?
|
| Osteoporosis | 1 | 2008 | 122 | 0.070 |
Why?
|
| Protein Transport | 1 | 2009 | 421 | 0.070 |
Why?
|
| Daunorubicin | 1 | 2007 | 78 | 0.070 |
Why?
|
| NIH 3T3 Cells | 1 | 2007 | 110 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2007 | 112 | 0.070 |
Why?
|
| N-Methylaspartate | 1 | 2006 | 51 | 0.070 |
Why?
|
| Liver | 2 | 2008 | 1208 | 0.070 |
Why?
|
| Lymphopoiesis | 1 | 2007 | 48 | 0.070 |
Why?
|
| Neurotoxins | 1 | 2006 | 49 | 0.070 |
Why?
|
| DNA | 4 | 2004 | 1308 | 0.070 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 333 | 0.070 |
Why?
|
| Cycloheximide | 2 | 2006 | 56 | 0.070 |
Why?
|
| Interleukin-1 | 1 | 2006 | 72 | 0.070 |
Why?
|
| 3T3 Cells | 2 | 2006 | 97 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 196 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 123 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2008 | 446 | 0.060 |
Why?
|
| Proteins | 2 | 2002 | 787 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 740 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 1991 | 788 | 0.060 |
Why?
|
| HIV Long Terminal Repeat | 2 | 1996 | 4 | 0.060 |
Why?
|
| Gene Products, tax | 2 | 1994 | 4 | 0.060 |
Why?
|
| Human T-lymphotropic virus 1 | 2 | 1994 | 14 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 177 | 0.060 |
Why?
|
| Genes, MHC Class I | 2 | 1995 | 48 | 0.060 |
Why?
|
| Antioxidants | 1 | 2006 | 226 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2008 | 596 | 0.060 |
Why?
|
| NF-KappaB Inhibitor alpha | 6 | 2003 | 42 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2009 | 2017 | 0.060 |
Why?
|
| Chemokines, CC | 1 | 2003 | 36 | 0.060 |
Why?
|
| Cell Movement | 2 | 2004 | 784 | 0.060 |
Why?
|
| Dinoprostone | 1 | 2023 | 70 | 0.060 |
Why?
|
| Lymphoid Tissue | 1 | 2003 | 57 | 0.060 |
Why?
|
| Immunomodulation | 1 | 2023 | 58 | 0.060 |
Why?
|
| Ankyrins | 2 | 1993 | 23 | 0.050 |
Why?
|
| Antibodies, Bacterial | 2 | 1994 | 100 | 0.050 |
Why?
|
| Viral Envelope Proteins | 1 | 2003 | 94 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2004 | 353 | 0.050 |
Why?
|
| Lysosomes | 1 | 2003 | 111 | 0.050 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1993 | 135 | 0.050 |
Why?
|
| Bacterial Adhesion | 2 | 1993 | 84 | 0.050 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2002 | 30 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 207 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2004 | 576 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2003 | 127 | 0.050 |
Why?
|
| Ligases | 1 | 2002 | 45 | 0.050 |
Why?
|
| Lymphotoxin beta Receptor | 3 | 2008 | 29 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 589 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 432 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2001 | 35 | 0.050 |
Why?
|
| Plasmids | 1 | 2002 | 291 | 0.050 |
Why?
|
| Systems Analysis | 1 | 2021 | 17 | 0.050 |
Why?
|
| Proteasome Inhibitors | 1 | 2021 | 52 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2021 | 40 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2021 | 94 | 0.050 |
Why?
|
| Paraffin Embedding | 1 | 2021 | 78 | 0.050 |
Why?
|
| Formaldehyde | 1 | 2021 | 52 | 0.050 |
Why?
|
| Metabolome | 1 | 2021 | 49 | 0.050 |
Why?
|
| Proteolysis | 1 | 2021 | 110 | 0.050 |
Why?
|
| Proteome | 1 | 2021 | 132 | 0.040 |
Why?
|
| Kinetics | 3 | 2003 | 1528 | 0.040 |
Why?
|
| Transcription Factor RelB | 4 | 2005 | 7 | 0.040 |
Why?
|
| Antigens | 1 | 2021 | 229 | 0.040 |
Why?
|
| Contractile Proteins | 1 | 2000 | 57 | 0.040 |
Why?
|
| Caspase 8 | 3 | 2004 | 34 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 1999 | 34 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 41 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 1999 | 159 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2000 | 289 | 0.040 |
Why?
|
| Dimerization | 2 | 2009 | 143 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2002 | 681 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2000 | 212 | 0.040 |
Why?
|
| Osteopetrosis | 1 | 1997 | 2 | 0.040 |
Why?
|
| Toxoplasmosis, Animal | 1 | 1998 | 20 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 1998 | 98 | 0.040 |
Why?
|
| Antigens, Surface | 2 | 1999 | 103 | 0.040 |
Why?
|
| Neurons | 1 | 2006 | 1584 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 1997 | 231 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 1998 | 169 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2017 | 100 | 0.040 |
Why?
|
| Epithelium | 2 | 2010 | 325 | 0.040 |
Why?
|
| Antibody Formation | 1 | 1998 | 171 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 193 | 0.040 |
Why?
|
| Proto-Oncogenes | 1 | 1997 | 61 | 0.040 |
Why?
|
| Toxoplasma | 1 | 1998 | 116 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1999 | 300 | 0.040 |
Why?
|
| Thymus Gland | 1 | 1997 | 197 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 1997 | 221 | 0.030 |
Why?
|
| Molecular Weight | 2 | 1994 | 331 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 1800 | 0.030 |
Why?
|
| Toxoplasmosis | 1 | 1997 | 66 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 1997 | 178 | 0.030 |
Why?
|
| Rats | 3 | 2008 | 4041 | 0.030 |
Why?
|
| Serum Response Factor | 1 | 1996 | 45 | 0.030 |
Why?
|
| Influenza A virus | 1 | 1997 | 169 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1996 | 127 | 0.030 |
Why?
|
| Transcriptome | 1 | 2021 | 631 | 0.030 |
Why?
|
| beta 2-Microglobulin | 1 | 1995 | 24 | 0.030 |
Why?
|
| Ubiquitins | 1 | 1996 | 38 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1995 | 65 | 0.030 |
Why?
|
| Protein Precursors | 2 | 1993 | 140 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2015 | 44 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 1997 | 309 | 0.030 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1993 | 81 | 0.030 |
Why?
|
| Genes, myc | 1 | 2015 | 39 | 0.030 |
Why?
|
| Telomere Homeostasis | 1 | 2015 | 30 | 0.030 |
Why?
|
| Lysine | 1 | 1996 | 150 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 100 | 0.030 |
Why?
|
| Macromolecular Substances | 4 | 1999 | 177 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 1999 | 556 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2015 | 69 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1997 | 565 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 102 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2015 | 65 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 1840 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1995 | 201 | 0.030 |
Why?
|
| Stem Cells | 1 | 1997 | 372 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 397 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 1995 | 261 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1994 | 92 | 0.030 |
Why?
|
| Vaccines, Inactivated | 1 | 1994 | 29 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2014 | 16 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 1999 | 1525 | 0.030 |
Why?
|
| Bacterial Vaccines | 1 | 1994 | 43 | 0.030 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2014 | 49 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1993 | 47 | 0.030 |
Why?
|
| Immunization | 1 | 1994 | 161 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1994 | 273 | 0.030 |
Why?
|
| Rabbits | 1 | 1994 | 639 | 0.030 |
Why?
|
| Compressive Strength | 1 | 2013 | 24 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2013 | 36 | 0.030 |
Why?
|
| Hardness | 1 | 2013 | 21 | 0.030 |
Why?
|
| Anisotropy | 1 | 2013 | 63 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1993 | 122 | 0.030 |
Why?
|
| Tretinoin | 1 | 1993 | 128 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1992 | 29 | 0.030 |
Why?
|
| Caspase 9 | 2 | 2003 | 49 | 0.030 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2015 | 261 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2012 | 23 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2014 | 167 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1993 | 511 | 0.030 |
Why?
|
| HIV | 1 | 1992 | 48 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 1992 | 112 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 293 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2013 | 253 | 0.030 |
Why?
|
| DNA Primers | 2 | 2006 | 543 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 247 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 1999 | 137 | 0.020 |
Why?
|
| Cell Division | 2 | 2006 | 696 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 2 | 2 | 2002 | 6 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 759 | 0.020 |
Why?
|
| Coculture Techniques | 2 | 2003 | 174 | 0.020 |
Why?
|
| Macrolides | 1 | 1991 | 31 | 0.020 |
Why?
|
| Th17 Cells | 1 | 2011 | 85 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2011 | 151 | 0.020 |
Why?
|
| RNA | 1 | 2015 | 580 | 0.020 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2010 | 8 | 0.020 |
Why?
|
| HMGB Proteins | 1 | 2010 | 4 | 0.020 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2010 | 5 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 171 | 0.020 |
Why?
|
| Mesocricetus | 1 | 2010 | 105 | 0.020 |
Why?
|
| Clone Cells | 1 | 2010 | 214 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1991 | 150 | 0.020 |
Why?
|
| Cells | 1 | 2010 | 32 | 0.020 |
Why?
|
| Genes, Immunoglobulin | 1 | 2010 | 111 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2010 | 215 | 0.020 |
Why?
|
| Trans-Activators | 1 | 1993 | 443 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2014 | 430 | 0.020 |
Why?
|
| Carcinogens | 1 | 2010 | 111 | 0.020 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2009 | 7 | 0.020 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2009 | 10 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2010 | 159 | 0.020 |
Why?
|
| Protein Conformation | 2 | 2008 | 892 | 0.020 |
Why?
|
| Arthritis | 1 | 2009 | 47 | 0.020 |
Why?
|
| Cricetinae | 1 | 2010 | 558 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 1552 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2010 | 163 | 0.020 |
Why?
|
| Paraquat | 1 | 2008 | 9 | 0.020 |
Why?
|
| Osteoarthritis | 1 | 2009 | 74 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 306 | 0.020 |
Why?
|
| Intraocular Pressure | 1 | 2008 | 57 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2009 | 156 | 0.020 |
Why?
|
| Finite Element Analysis | 1 | 2008 | 78 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2008 | 85 | 0.020 |
Why?
|
| Pleural Neoplasms | 1 | 2010 | 198 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2008 | 103 | 0.020 |
Why?
|
| Gene Expression | 1 | 1992 | 1310 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2008 | 154 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2008 | 117 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2008 | 302 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 1088 | 0.020 |
Why?
|
| Immune System | 1 | 2008 | 97 | 0.020 |
Why?
|
| Models, Animal | 1 | 2008 | 276 | 0.020 |
Why?
|
| Hepatectomy | 1 | 2008 | 171 | 0.020 |
Why?
|
| Mesothelioma | 1 | 2010 | 323 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 1993 | 892 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 557 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 27 | 0.020 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2006 | 6 | 0.020 |
Why?
|
| Metaphase | 1 | 2006 | 25 | 0.020 |
Why?
|
| Retina | 1 | 2008 | 220 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 1993 | 1412 | 0.020 |
Why?
|
| Calcium | 2 | 2006 | 1175 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2006 | 66 | 0.020 |
Why?
|
| Insulinoma | 1 | 2006 | 37 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2010 | 689 | 0.020 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2006 | 73 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2005 | 41 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2008 | 458 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2004 | 49 | 0.010 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 25 | 0.010 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2004 | 51 | 0.010 |
Why?
|
| Proteomics | 1 | 2006 | 230 | 0.010 |
Why?
|
| Ionomycin | 2 | 1995 | 21 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2006 | 313 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2009 | 1303 | 0.010 |
Why?
|
| DNA Damage | 1 | 2006 | 371 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2008 | 1098 | 0.010 |
Why?
|
| Receptors, CCR7 | 1 | 2003 | 16 | 0.010 |
Why?
|
| Chemokine CCL21 | 1 | 2003 | 16 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2003 | 31 | 0.010 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2003 | 28 | 0.010 |
Why?
|
| Aging | 1 | 2008 | 718 | 0.010 |
Why?
|
| U937 Cells | 1 | 2003 | 32 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2003 | 117 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 269 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 645 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 2 | 1996 | 162 | 0.010 |
Why?
|
| Leukocytes | 1 | 2003 | 204 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 2367 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2003 | 195 | 0.010 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2002 | 13 | 0.010 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2002 | 31 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 6817 | 0.010 |
Why?
|
| Multigene Family | 2 | 1994 | 203 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 794 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2005 | 548 | 0.010 |
Why?
|
| Insulin | 1 | 2006 | 1146 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2002 | 342 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2000 | 6 | 0.010 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2000 | 11 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2006 | 674 | 0.010 |
Why?
|
| Filamins | 1 | 2000 | 22 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2000 | 58 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2000 | 135 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1942 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1999 | 217 | 0.010 |
Why?
|
| Mutation | 2 | 2003 | 4143 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1999 | 268 | 0.010 |
Why?
|
| Cell Lineage | 1 | 1999 | 291 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1997 | 26 | 0.010 |
Why?
|
| Lung | 1 | 2003 | 1262 | 0.010 |
Why?
|
| HIV Enhancer | 1 | 1996 | 1 | 0.010 |
Why?
|
| Oncogene Proteins v-rel | 1 | 1996 | 1 | 0.010 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1996 | 9 | 0.010 |
Why?
|
| Serine | 1 | 1997 | 104 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1996 | 35 | 0.010 |
Why?
|
| Interferon Regulatory Factor-2 | 1 | 1995 | 4 | 0.010 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 1995 | 19 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1995 | 63 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1996 | 141 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 19178 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1995 | 306 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 418 | 0.010 |
Why?
|
| Zinc Compounds | 1 | 1994 | 6 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1994 | 69 | 0.010 |
Why?
|
| Chlorides | 1 | 1994 | 103 | 0.010 |
Why?
|
| Point Mutation | 1 | 1995 | 245 | 0.010 |
Why?
|
| Endopeptidases | 1 | 1994 | 118 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1995 | 446 | 0.010 |
Why?
|
| Mitogens | 1 | 1994 | 62 | 0.010 |
Why?
|
| Embryonal Carcinoma Stem Cells | 1 | 1993 | 2 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1994 | 284 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 1993 | 39 | 0.010 |
Why?
|
| Endopeptidase K | 1 | 1993 | 12 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1995 | 451 | 0.010 |
Why?
|
| Membrane Fusion | 1 | 1993 | 37 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1993 | 258 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1995 | 395 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 1993 | 359 | 0.010 |
Why?
|
| Lymphoma, B-Cell | 1 | 1992 | 106 | 0.010 |
Why?
|
| Adult | 1 | 1999 | 26631 | 0.000 |
Why?
|